The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Documentation patterns and impact on observed side effects of the CANKADO ehealth application: An exploratory analysis of the PreCycle trial.
 
Tom Degenhardt
No Relationships to Disclose
 
Nadia Harbeck
Stock and Other Ownership Interests - West German Study Group
Honoraria - Amgen; AstraZeneca; Genomic Health; Novartis; Pfizer; Pierre Fabre; Roche; Zodiac Pharma
Consulting or Advisory Role - Agendia; AstraZeneca; Celgene; Daiichi Sankyo; Lilly; Merck Sharp & Dohme; Novartis; Odonate Therapeutics; Pfizer; Pierre Fabre; Roche/Genentech; Sandoz; Seagen; West German Study Group (I)
Research Funding - Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Peter A. Fasching
Honoraria - Amgen; AstraZeneca; BioNTech (Inst); Celgene; Cepheid (Inst); Daiichi Sankyo; Eisai; Hexal; Lilly; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Macrogenics; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Research Funding - BioNTech (Inst); Cepheid (Inst); Novartis (Inst)
 
Rachel Wuerstlein
No Relationships to Disclose
 
Diana Lüftner
No Relationships to Disclose
 
Ronald E. Kates
No Relationships to Disclose
 
Johannes Schumacher
No Relationships to Disclose
 
Claudia Wenzel
Employment - CANKADO
 
Timo Schinkoethe
Leadership - CANKADO
Stock and Other Ownership Interests - CANKADO
 
Marcus Schmidt
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AMGEN; AstraZeneca; Myelo Therapeutics GmbH; Novartis; Pantarhei Bioscience; Pfizer; Roche
Research Funding - AstraZeneca (Inst); BioNTech (Inst); Myelo Therapeutics GmbH (Inst); Pantarhei Bioscience (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche